Hull Hans

Pliant Therapeutics, Inc. · Chief Business Officer

Hull Hans is listed in public filings as officer: Chief Business Officer. This Hull Hans insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Pliant Therapeutics, Inc. (PLRX). Investors use Hull Hans's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Pliant Therapeutics, Inc.PLRX$179k15.9k sharesSellJan 17, 2025$11.20--